Deutsch English Français

Contact

EP0812827

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0812827

EP0812827 - Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 09.07.2010 Database last updated on 23.12.2024
Most recent event Tooltip	09.07.2010	No opposition filed within time limit	published on 11.08.2010 [2010/32]
Applicant(s)	For all designated states Sumitomo Chemical Company, Limited 27-1, Shinkawa 2-chome, Chuo-ku Tokyo 104-8260 / JP
	[2009/36]
Former [2005/01]	For all designated states Sumitomo Chemical Company, Limited 27-1, Shinkawa 2-chome, Chuo-ku Tokyo 104-8260 / JP
Former [2004/46]	For all designated states Sumitomo Chemical Company, Limited 5-33, Kitahama 4-chome, Chuo-ku Osaka-shi Osaka 541-8550 / JP
Former [1997/51]	For all designated states SUMIKA FINE CHEMICALS Co., Ltd. 3-1-21, Utajima, Nishiyodogawa-ku Osaka-shi, Osaka / JP
Inventor(s)	01 / Sugi, Kiyoshi, c/o Sumika Fine Chem. Co., Ltd. Central Research Lab., 1-21 Utajima 3-chome Nishiyodogawa-ku, Osaka-shi, Osaka / JP
	02 / Itaya, Nobushige, c/o Sumika Fine Chem. Co., Ltd. Central Research Lab., 1-21 Utajima 3-chome Nishiyodogawa-ku, Osaka-shi, Osaka / JP
	03 / Katsura, Tadashi, c/o Sumika Fine Chem. Co., Ltd. Central Research Lab., 1-21 Utajima 3-chome Nishiyodogawa-ku, Osaka-shi, Osaka / JP
	04 / Igi, Masami, c/o Sumika Fine Chem. Co., Ltd. Central Research Lab., 1-21 Utajima 3-chome Nishiyodogawa-ku, Osaka-shi, Osaka / JP
	05 / Yamazaki, Shigeya, c/o Sumika Fine Chem. Co., Ltd. Central Research Lab., 1-21 Utajima 3-chome Nishiyodogawa-ku, Osaka-shi, Osaka / JP
	06 / Ishibashi, Taro, c/o Sumika Fine Chem. Co., Ltd. Central Research Lab., 1-21 Utajima 3-chome Nishiyodogawa-ku, Osaka-shi, Osaka / JP
	07 / Yamaoka, Teiji, c/o Sumika Fine Chem. Co., Ltd. Central Research Lab., 1-21 Utajima 3-chome Nishiyodogawa-ku, Osaka-shi, Osaka / JP
	08 / Kawada, Yoshihiro, c/o Sumika Fine Chem. Co., Ltd. Central Research Lab., 1-21 Utajima 3-chome Nishiyodogawa-ku, Osaka-shi, Osaka / JP
	09 / Tagami, Yayoi, c/o Sumika Fine Chem. Co., Ltd. Central Research Lab., 1-21 Utajima 3-chome Nishiyodogawa-ku, Osaka-shi, Osaka / JP
	[1997/51]
Representative(s)	Gillard, Richard Edward, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
	[N/P]
Former [2010/29]	Gillard, Richard Edward, et al Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB
Former [1997/51]	Marchant, James Ian, et al Elkington and Fife, Prospect House, 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB
Application number, filing date	97303647.8	29.05.1997
	[1997/51]
Priority number, date	JP19960175893	13.06.1996 Original published format: JP 17589396
	JP19960294585	15.10.1996 Original published format: JP 29458596
	JP19960303838	29.10.1996 Original published format: JP 30383896
	JP19960326177	20.11.1996 Original published format: JP 32617796
	JP19970050980	18.02.1997 Original published format: JP 5098097
	[1997/51]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP0812827
	Date:	17.12.1997
	Language:	EN
	[1997/51]
	Type:	B1 Patent specification
	No.:	EP0812827
	Date:	02.09.2009
	Language:	EN
	[2009/36]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	30.10.1997
Classification	IPC:	C07D211/22	[1997/51]
	CPC:	C07D405/12 (EP,US); C07D211/22 (EP,US); C07D211/60 (EP,US); C07D211/76 (EP,US)
Designated contracting states	BE, CH, DE, ES, FR, GB, IT, LI, NL, SE [1997/51]
Title	German:	Piperidin Derivative als Zwischenprodukte zur Herstellung von Paroxetine und Verfahren zu ihrer Herstellung	[1997/51]
	English:	Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation	[1997/51]
	French:	Dérivés de pipéridine comme intermédiaire pour la production de paroxétine et procédé pour leur préparation	[1997/51]
Examination procedure	21.01.1998	Examination requested [1998/12]
	21.02.1998	Observations by third parties
	02.11.1998	Observations by third parties
	04.09.2000	Amendment by applicant (claims and/or description)
	10.08.2001	Despatch of a communication from the examining division (Time limit: M06)
	13.02.2002	Reply to a communication from the examining division
	20.02.2003	Despatch of a communication from the examining division (Time limit: M06)
	18.08.2003	Reply to a communication from the examining division
	23.09.2004	Despatch of a communication from the examining division (Time limit: M04)
	25.01.2005	Reply to a communication from the examining division
	25.11.2008	Despatch of a communication from the examining division (Time limit: M04)
	23.01.2009	Reply to a communication from the examining division
	13.03.2009	Communication of intention to grant the patent
	22.07.2009	Fee for grant paid
	22.07.2009	Fee for publishing/printing paid
Divisional application(s)	EP03077856.7 / EP1384711
	EP03077857.5 / EP1394160
	EP03077858.3 / EP1384720
Opposition(s)	03.06.2010	No opposition filed within time limit [2010/32]
Fees paid	Renewal fee
	12.05.1999	Renewal fee patent year 03
	15.05.2000	Renewal fee patent year 04
	14.05.2001	Renewal fee patent year 05
	14.05.2002	Renewal fee patent year 06
	13.05.2003	Renewal fee patent year 07
	13.05.2004	Renewal fee patent year 08
	12.05.2005	Renewal fee patent year 09
	10.05.2006	Renewal fee patent year 10
	14.05.2007	Renewal fee patent year 11
	14.05.2008	Renewal fee patent year 12
	12.05.2009	Renewal fee patent year 13
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]EP0190496 (BEECHAM GROUP PLC [GB]) [X] 1,5,7-9 * column W *;
		[X]EP0266574 (FERROSAN AS [DK]) [X] 1,4 * column W *;
		[YDX]DE2404113 (FERROSAN AS) [YD] 4-14 * column W * [X] 1;
		[YX]US4007196 (CHRISTENSEN JORGEN ANDERS, et al) [Y] 4-14 * column W * [X] 1;
		[YD]EP0223334 (BEECHAM GROUP PLC [GB]) [YD] 4-14 * column W *;
		[Y]WO9525732 (FERRER INT [ES], et al) [Y] 4-14 * column W *;
		[Y]EP0223403 (BEECHAM GROUP PLC [GB]) [Y] 4-14 * column W *;
		[Y]WO9421609 (SMITHKLINE BEECHAM PLC [GB], et al) [Y] 4-14 * column W *;
		[PX]WO9636636 (NOVO NORDISK AS [DK], et al) [PX] 1-14 * column W *
		[X] - ENGELSTOFT M ET AL, "SYNTHESIS AND 5-HT MODULATING ACTIVITY OF STEREOISOMERS OF 3-PHENOXYMETHYL-4-PHENYLPIPERIDINES", ACTA CHEMICA SCANDINAVICA, (199602), vol. 50, no. 2, pages 164 - 169, XP000645441 [X] 1,4 * page 166; table 1 *
		[X] - MATHIS,C.A. ET AL., "Binding Potency of Paroxetine Analogues for the 5-Hydroxytryptamine Uptake Complex", J.PHARM.PHARMACOL., (199210), vol. 44, no. 10, pages 801 - 805, XP002042309 [X] 1 * page 803; table 1 *
		[X] - HERDELS,C. ET AL., "Synthesis of Homochiral Piperidine Derivatives from S-Glutamic Acid. Steroeselective 1,4-Addition of Organocuprates to a delta-3-piperidine-2-one. A Paroxetine Analogue.", TETRAHEDRON:ASYMETRY, OXFORD, (199603), vol. 7, no. 3, pages 867 - 884, XP002042117 [X] 1-14 * column W * DOI: http://dx.doi.org/10.1016/0957-4166(96)00085-7
		[X] - WILLOCKS K ET AL, "THE SYNTHESIS OF 14C-3S,4R-4-(4-FLUOROPHENYL)-3- (3,4-METHYLENEDIOXYPHENOXYMETHYL)PIPERIDINE HYDROCHLORIDE (BRL 29060A), AND MECHANISTIC STUDIES USING CARBON-13 LABELLING", JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, (1993), vol. 33, no. 8, pages 783 - 794, XP000645839 [X] 4-14 * column W *
		[X] - BUXTON P C ET AL, "SOLID-STATE FORMS OF PAROXETINE HYDROCHLORIDE", INTERNATIONAL JOURNAL OF PHARMACEUTICS, (19880101), vol. 42, pages 135 - 143, XP000572028 [X] 9-14 * column W * DOI: http://dx.doi.org/10.1016/0378-5173(88)90169-X
	other	EP0802185
		ES2128235
		ES2121682

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p